Internephron heterogeneity of growth factors and sclerosis.
Tanaka
R
R
Department of Pathology, Vanderbilt University Medical Center, Nashville, TN 37232.
Fogo
A
A
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001920:Bradykinin / Q000037:antagonists & inhibitors; D005355:Fibrosis; D015870:Gene Expression; D006830:Hydralazine / Q000494:pharmacology; D006852:Hydrochlorothiazide / Q000494:pharmacology; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D007678:Kidney Glomerulus / Q000187:drug effects / Q000473:pathology; D009399:Nephrons / Q000187:drug effects / Q000473:pathology*; D010982:Platelet-Derived Growth Factor / Q000096:biosynthesis; D011507:Proteinuria; D011691:Puromycin / Q000633:toxicity; D012333:RNA, Messenger / Q000032:analysis / Q000096:biosynthesis; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013997:Time Factors
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D010982:Platelet-Derived Growth Factor; D012333:RNA, Messenger; D006852:Hydrochlorothiazide; D006830:Hydralazine; D011691:Puromycin; D012110:Reserpine; D001920:Bradykinin